Related Experiment Video
Updated: Jun 23, 2025

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
Anti-Inflammatory Activity of Pyrazolo[1,5-a]quinazolines
Letizia Crocetti1, Andrei I Khlebnikov2, Gabriella Guerrini1
1Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA), Pharmaceutical and Nutraceutical Section, University of Florence, Via Ugo Schiff 6, 50019 Florence, Italy.
Researchers identified novel anti-inflammatory compounds from a pyrazolo[1,5-a]quinazoline library. These compounds target mitogen-activated protein kinases (MAPKs), showing potential for new anti-inflammatory drug development.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Molecular Biology
Background:
- Chronic inflammation is a key factor in numerous diseases, necessitating the development of effective therapeutic strategies.
- Controlling inflammatory responses is a critical goal in drug discovery and development.
Purpose of the Study:
- To discover novel anti-inflammatory compounds by synthesizing and screening a library of pyrazolo[1,5-a]quinazoline derivatives.
- To identify specific molecular targets for these novel anti-inflammatory agents.
Main Methods:
- Synthesis and screening of 80 pyrazolo[1,5-a]quinazoline compounds for inhibition of lipopolysaccharide (LPS)-induced nuclear factor κB (NF-κB) activity.
- Pharmacophore mapping and molecular modeling to predict and validate interactions with mitogen-activated protein kinases (MAPKs).
Main Results:
- Thirteen compounds exhibited anti-inflammatory activity (IC50 < 50 µM) in a cell-based assay.
- Compounds 13i and 16 showed potent activity and were predicted to bind to MAPKs, including ERK2, p38α, and JNK3.
- Molecular modeling confirmed binding to JNK3 with high complementarity, and compounds demonstrated micromolar binding affinities for JNK1, JNK2, and JNK3.
Conclusions:
- The pyrazolo[1,5-a]quinazoline scaffold is a promising basis for developing novel anti-inflammatory drugs.
- Targeting MAPKs, particularly JNK family kinases, represents a viable strategy for anti-inflammatory drug development.
Related Concept Videos
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Drugs for Treatment of Ulcerative Colitis in IBD
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antipsychotic Drugs: Typical and Atypical Agents
Basicity of Heterocyclic Aromatic Amines
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

